Introduction

The BGMA represents the views of our members and the industry in general focussing on areas and topics we believe are important in order to promote and sustain a thriving competitive generic medicines industry in the UK. The core role of a successful generic medicines manufacturing sector is to get the right medicines at the right time to patients to improve quality of life. This work also stimulates the originator sector to continue research-based activity which results in new and improved medicines for patients.

There are a number of issues, which are important to our members, in which we engage with a range of stakeholders from parliamentary representatives and government departments, through to the European Union.